Kwon Hye-Mee, Jun In-Gu, Kim Kyoung-Sun, Moon Young-Jin, Huh In Young, Lee Jungmin, Song Jun-Gol, Hwang Gyu-Sam
Department of Anesthesiology and Pain Medicine, Laboratory for Cardiovascular Dynamics, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.
Brain Sci. 2021 Mar 31;11(4):445. doi: 10.3390/brainsci11040445.
Postoperative hemorrhagic stroke (HS) is a rare yet devastating complication after liver transplantation (LT). Unruptured intracranial aneurysm (UIA) may contribute to HS; however, related data are limited. We investigated UIA prevalence and aneurysmal subarachnoid hemorrhage (SAH) and HS incidence post-LT. We identified risk factors for 1-year HS and constructed a prediction model. This study included 3544 patients who underwent LT from January 2008 to February 2019. Primary outcomes were incidence of SAH, HS, and mortality within 1-year post-LT. Propensity score matching (PSM) analysis and Cox proportional hazard analysis were performed. The prevalence of UIAs was 4.63% ( = 164; 95% confidence interval (CI), 3.95-5.39%). The 1-year SAH incidence was 0.68% (95% CI, 0.02-3.79%) in patients with UIA. SAH and HS incidence and mortality were not different between those with and without UIA before and after PSM. Cirrhosis severity, thrombocytopenia, inflammation, and history of SAH were identified as risk factors for 1-year HS. UIA presence was not a risk factor for SAH, HS, or mortality in cirrhotic patients post-LT. Given the fatal impact of HS, a simple scoring system was constructed to predict 1-year HS risk. These results enable clinical risk stratification of LT recipients with UIA and help assess perioperative HS risk before LT.
术后出血性卒中(HS)是肝移植(LT)后一种罕见但具有毁灭性的并发症。未破裂颅内动脉瘤(UIA)可能导致HS;然而,相关数据有限。我们调查了LT后UIA的患病率、动脉瘤性蛛网膜下腔出血(SAH)和HS的发生率。我们确定了1年HS的危险因素并构建了一个预测模型。本研究纳入了2008年1月至2019年2月期间接受LT的3544例患者。主要结局是LT后1年内SAH、HS的发生率和死亡率。进行了倾向评分匹配(PSM)分析和Cox比例风险分析。UIA的患病率为4.63%(n = 164;95%置信区间(CI),3.95 - 5.39%)。UIA患者的1年SAH发生率为0.68%(95%CI,0.02 - 3.79%)。PSM前后,有UIA和无UIA患者的SAH、HS发生率及死亡率无差异。肝硬化严重程度、血小板减少、炎症和SAH病史被确定为1年HS的危险因素。LT后肝硬化患者中UIA的存在不是SAH、HS或死亡的危险因素。鉴于HS的致命影响,构建了一个简单的评分系统来预测1年HS风险。这些结果能够对有UIA的LT受者进行临床风险分层,并有助于在LT前评估围手术期HS风险。